Dupixent GI expansion

Quote






I heard that the goal was end of April from a manager in a different division, A rep told me that one of the hiring managers said that they would be moving faster, so God only knows. Probably doing it in waves with all complete by the end of April. I know plenty of people at both companies. Co-promote is about the same as it is anywhere. Sometimes it’s good and sometimes it’s not depending on your partner. Also, the numbers don’t match, so you can have different rankings at each company for the same territory.
 












anonymous said:
More so, you’re sharing the sandbox with a Sanofi rep who you need to play nice with. Should be interesting in a rare disease market
Click to expand...

This sales force is ultimately being put together to launch the COPD indication late in 2022 and if Dupi doesn't get this indication this sales force will be gone. You dont need this many reps to sell EOE past the first year. The COPD indication is not a slam dunk either, do your homework before jumping onto this ship unless you have nothing else.
 






This is 100% false and just plain stupid! There is plenty of GI business. Had a ped GI tell me that he sees 3-4 EoE patients a week, half are new. There is no reason why pulm wouldn’t launch COPD. Allergy/ENT sells multiple indications.
 






anonymous said:
This is 100% false and just plain stupid! There is plenty of GI business. Had a ped GI tell me that he sees 3-4 EoE patients a week, half are new. There is no reason why pulm wouldn’t launch COPD. Allergy/ENT sells multiple indications.
Click to expand...

So 2 mirrored reps are going after a couple of patients a week which for most docs is actually pretty high. Most docs may see 1 new eoe patient a month if that so come back early next year and this sales force will have copd indication assuming Dupi gets that indication which is far from a done deal. Later dude!!
 






anonymous said:
I heard that the goal was end of April from a manager in a different division, A rep told me that one of the hiring managers said that they would be moving faster, so God only knows. Probably doing it in waves with all complete by the end of April. I know plenty of people at both companies. Co-promote is about the same as it is anywhere. Sometimes it’s good and sometimes it’s not depending on your partner. Also, the numbers don’t match, so you can have different rankings at each company for the same territory.
Click to expand...


So 2 reps calling on the exact same offices and targets, potentially both getting credit for the same script? (2 reps get credit for 1 script). However, the data for both companies doesn’t match?!

Do they coin toss for which rep gets the credit for 1 script?
 






This has always been a problem with Sanofi and Regenerons data. Regeneron scripts have always been short of Sanofi and the goals were always different. How hard can it be to look at both companies data and but the same data. Only Sanofi and Regeneron could make this simple thing hard.
 






anonymous said:
So 2 mirrored reps are going after a couple of patients a week which for most docs is actually pretty high. Most docs may see 1 new eoe patient a month if that so come back early next year and this sales force will have copd indication assuming Dupi gets that indication which is far from a done deal. Later dude!!
Click to expand...
 






anonymous said:
So 2 mirrored reps are going after a couple of patients a week which for most docs is actually pretty high. Most docs may see 1 new eoe patient a month if that so come back early next year and this sales force will have copd indication assuming Dupi gets that indication which is far from a done deal. Later dude!!
Click to expand...

I just spoke with a pediatric GI last week who sees at least 4 a week, 2 new, 2 f/u which are still potential. He's not even any kind of thought leader or specialists in EoE. The study for 1-11 year olds will be completed in 2023 as will the COPD data. COPD isn't expected to launch unitl 2024. Look at the damn investor presentations, moron. Also doing a P2 in Gastritis and Gastroenteritis. Later, clueless.
 












anonymous said:
I just spoke with a pediatric GI last week who sees at least 4 a week, 2 new, 2 f/u which are still potential. He's not even any kind of thought leader or specialists in EoE. The study for 1-11 year olds will be completed in 2023 as will the COPD data. COPD isn't expected to launch unitl 2024. Look at the damn investor presentations, moron. Also doing a P2 in Gastritis and Gastroenteritis. Later, clueless.
Click to expand...

well if you just spoke with a pediatric GI then part the fucking seas so we can all admire you from a far, what a prick!!
 






anonymous said:
This has always been a problem with Sanofi and Regenerons data. Regeneron scripts have always been short of Sanofi and the goals were always different. How hard can it be to look at both companies data and but the same data. Only Sanofi and Regeneron could make this simple thing hard.
Click to expand...


In my area Regeneron and Sanofi scripts numbers are close , however it is always Regeneron that has the higher scripts number . But we always end up ranked about the same in our respective sales forces .
 












anonymous said:
Spoken like an emotionally immature individual who cannot handle being wrong. The GI team is not being hired to transition to the COPD launch. You are wrong. Move along.
Click to expand...

You're exactly right, he's wrong. I've read this idiots same postings over on the Takeda board. He doesn't understand the size revenue stream these products generate. I'm fairly certain Sr Mgt is fully aware of the business opportunity at hand, as such they are hiring for full representation in each of these disease states. This is NOT retail pharmaceuticals, 1 script here is worth thousands of dollars.
 






The timeline to get dm’s hired for vacant positions and newly created will be end of march. Interviews have started now. Don’t know salary range for dm’s but for reps range 140-175k range depending on experience. That’s the mix in my district anyway.
 






anonymous said:
The timeline to get dm’s hired for vacant positions and newly created will be end of march. Interviews have started now. Don’t know salary range for dm’s but for reps range 140-175k range depending on experience. That’s the mix in my district anyway.
Click to expand...

Thanks! Had phone screen for rep position. Was told first interview next week, 2nd would be within 2-3 weeks after that. Panels after that in March. Offers out early April w/ start date end April/early May.
 
























Top Bottom
Back
Quote